FibroBiologics Inc. FBLG on Monday released the first batch of its CYWC628 drug product to support its Phase 1/2 clinical ...

(Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases ...

Treating a simple diabetic foot ulcer can cost $8,000; an infected one, $17,000. The main message for the average diabetic: Take off your socks and shoes at every visit to the doctor and ask that he ...

Guest: Michelle Diss (Nurse Practitioner). HealthLine is a fast paced show that keeps you informed of the latest developments in the worlds of medicine, health and wellness. Since January of 1996, ...

Oct. 13—(StatePoint) Foot ulcers develop in about 15% of the 25 million Americans living with diabetes and are a top cause of hospitalization. These ulcers can lead to serious complications, such as ...

Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biopharmaceutical company focused on cellular energy restoration therapeutic ...

Researchers have developed a new shoe insole technology that helps reduce the risk of diabetic foot ulcers, a dangerous open sore that can lead to hospitalization and leg, foot or toe amputations. The ...

The first sock measuring shear stress aimed at reducing the risk of foot ulcers for patients with diabetes is among several innovations being ...